shutterstock_696833128

We created and participated in tables of experts for the discussion and creation of guides and new products for the treatment and improvement of the quality of life of patients with osteoarthritis.

STUDY DELPHI SYSADOAS

shutterstock_709781023 (1)

Study based on the DELPHI method on the appropriate use in clinical practice of slow-acting drugs for osteoarthritis SYSADOAS (Symptomatic Slow Action Drugs for Osteoarthritis): Chondroitin Sulfate (CS), Glucosamine Sulfate (GLU) ) and the combination of both (CS + GLU) and diacerein. The study had the collaboration of a group of experts from the medical societies (SEMG, SEMERGEN, SER, among others) of OAFI.

RENACE

Did you know that Spain is the second longest country in the world behind Japan?

Do you know what the 14,000 people in Spain who have over 100 years of age have in common?

Does this initiative sound interesting? Are you keen to collaborate with us? In that case, we encourage you to contact us by writing to this email address: info@oafifoundation.com

The International Osteoarthritis Foundation (OAFI) and the Spanish Society of General Medicine (SEMG) have created the RENACE project (National Registry of Centenarians). A scientific research project with the aim of working together to create a Spanish census of people over 100 years of age and understand the factors related to longevity, whether genetic factors or patterns in their lifestyles. The study will focus especially on obtaining data focused on certain areas such as arthroses, cardiovascular, oncological, endocrinological and neurological

shutterstock_1092780644

Help us improve the quality of life of osteoarthritis patients